tradmap

TKNO Alpha Teknova, Inc.

$5.25 +6.38%

Healthcare · In Vitro & In Vivo Diagnostic Substances

Alpha Teknova, Inc. (TKNO) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $282 million. Shares last traded at $5.25, 21.1% below their 52-week high. Over the past year the stock is down 2.5%. Net profit margin is -42.6%, below the peer median of -3.8%. Revenue grew 7.4% year over year.

Market Cap
$282M
Shares Out
53.6M
EPS (TTM)
$-0.55
P/E Ratio
P/S Ratio
6.95
P/B Ratio
4.34
Dividend / Share
Dividend Yield
52-Week High
$6.66
52-Week Low
$1.91
Volume
9,658
Avg Vol (3m)
7,265.619

Performance

1W
+19.70%
1M
+41.26%
3M
+84.71%
6M
+13.25%
YTD
+34.40%
1Y
-2.50%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
64.71
SMA (50)
$3.87
SMA (200)
$3.94
Price vs SMA50
+35.83%
Price vs SMA200
+33.22%
ATR (14)
$0.40

Financials

Revenue
$41M
Net Income
$-17M
Gross Margin
33.2%
Operating Margin
-41.9%
Net Margin
-42.6%
Return on Equity
-26.6%
Return on Assets
-17.5%
Current Ratio
4.59
Debt / Equity
0.20
Revenue Growth (YoY)
+7.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.08 2026-05-07
FY 2025 $-0.32 2026-03-02
Q3 2025 $-0.23 2025-11-07
Q2 2025 $-0.15 2025-08-08
Q1 2026 $-0.09 2026-05-07
FY 2025 $-0.57 2026-03-02

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

TKNO vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap.

P/S vs peers
6.95 / 4.39 med
+58% premium
Net margin vs peers
-42.6% / -3.8% med
below median
1–14 of 14
IDXXIdexx Laboratories$44.3B41.8410.3024.6%+2.91%
LNTHLantheus Holdings, Inc.$6.8B28.974.3915.2%+0.67%
CLDXCelldex Therapeutics, Inc.$2.5B-9.84-1.47%
NTLAIntellia Therapeutics, Inc.$2.2B-5.30+2.25%
NEOGNeogen Corp$2.0B-1.85+4.14%
QDELQuidelortho Corp$932M+4.27%
ACHVAchieve Life Sciences, Inc.$496M-9.07-9.72%
MYGNMyriad Genetics Inc$429M-1.170.52-44.4%+3.65%
TKNOAlpha Teknova, Inc.$282M-16.326.95-42.6%+6.38%
IMDXInsight Molecular Diagnostics Inc.$176M-3510.5043.48-1.2%+2.25%
ICCCIMMUCELL CORP /DE/$86M-82.253.09-3.8%+0.53%
QCLSQ/C TECHNOLOGIES, INC.$32M-2.72+4.28%
VNRXVOLITIONRX LTD$12M-0.52+6.14%
CDIOCardio Diagnostics Holdings, Inc.$6M+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.